Tenor ALEXANDER NISHIBUN is gaining recognition for his vibrant sound, musical versatility, and engaging presence. His music has been characterized as “a delight…” and “capable of stealing the show” (Portland Press Herald). His varied roles have included Nemorino from L’Elisir d’amore, Prunier from La Rondine, Fenton from Falstaff, Tamino and Monostatos from Die Zauberflöte, and Frederic from The Pirates of Penzance. Nishibun has sung with the Portland Opera YAP, the Boston Early Music Festival YAP during their nationally acclaimedNiobe, Regina di Tebe (Steffani) production, and continues to perform widely in the greater Boston area.
A frequent oratorio soloist, Nishibun’s recent and upcoming performances include Handel’s Messiah, Buxtehude’s Membra Jesu Nostri, Haydn’s The Creation, Bach’s Mass in B minor, Mozart’s Requiem, Bach’s Magnificat, Handel’sDixit Dominus, Mozart’s Davide Penitente. His concert work also includes various Monteverdi works with the Cherry Street Singers as well as recital works in collaboration with the Boston Art Song Society.
In conjunction with his solo work, Nishibun is an active vocal chamber music artist. He performs across the United States with the Skylark Vocal Ensemble, Vox Humana, Kinnara Ensemble, Les Canards Chantants, the GRAMMY® Award-winning Handel & Haydn Society, the Blue Heron Renaissance Choir, and the Boston Cecilia. A regular studio recording artist, his most recent work can be heard on the Skylark Vocal Ensemble’s newest album, Crossing Over. In addition, he will record works with the Blue Heron Renaissance Choir as well as Kinnara Ensemble this season.
His work within the Boston community can be seen in his frequent appearances with Trinity Church (Copley Square) as their staff tenor, Church of the Advent (Beacon Hill), and Marsh Chapel of Boston University where he was a choral scholar. Nishibun works regularly with the child-choristers of Trinity Church as well as leading masterclasses and workshops across the United States with the Skylark Vocal Ensemble and Vox Humana.